Working… Menu
Trial record 1 of 2 for:    onivyde | Small Cell Lung Cancer
Previous Study | Return to List | Next Study

Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer (RESILIENT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03088813
Recruitment Status : Active, not recruiting
First Posted : March 23, 2017
Last Update Posted : February 24, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : December 2022